z-logo
Premium
Flow cytometric analysis of nephroblastomas and related neoplasms
Author(s) -
Schmidt Dietmar,
Wiedemann Bernd,
Keil Wolfgang,
Sprenger Ernst,
Harms Dieter
Publication year - 1986
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19861201)58:11<2494::aid-cncr2820581124>3.0.co;2-j
Subject(s) - pathology , wilms' tumor , flow cytometry , medicine , kidney , sarcoma , cytogenetics , oncology , biology , chromosome , immunology , genetics , gene
A total of 59 cases of nephroblastoma and related neoplasms were studied by flow cytometry of paraffin‐embedded tissue. According to clinical prognosis, cases were subdivided into three groups: Group 1 (low risk) consisted of congenital mesoblastic nephroma (n = 13) and cystic, partially differentiated nephroblastoma (n = 2). Group 2 (intermediate risk) comprised the various subtypes of „typical” nephroblastoma (n = 24) including cases of fetal rhabdomyomatous nephroblastoma (n = 4). In group 3 (high risk) there were cases of anaplastic nephroblastoma (n = 3), clear cell sarcoma of the kidney or „bone metastasizing renal tumor of childhood” (n = 7), and malignant rhabdoid tumor of the kidney (n = 6). The three clinically different groups of tumors also varied in the proportion of cases with aneuploid tumor DNA stemlines, in S‐phase fractions, and in proliferation indices (PI = S + G 2 + M). Group 1 was generally characterized by a small number of cases with aneuploid tumor DNA stemlines and low values for S‐phase fractions and PI, whereas Group 3 showed the largest number of cases with aneuploid tumor DNA stemlines and high values for S‐phase fractions and PI. Group 2 was in between. It is concluded that flow cytometry on paraffin‐embedded tissue from pediatric tumors may be a useful adjunct in determining prognosis, and that the subdivision of nephroblastomas and related neoplasms into three prognostically different groups is warranted.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here